Abigail Rotberg
Far Rockaway, NYNPI 1952046203
Payments from drug & device makers
$3,223in general payments, 2019–2025
Across 148 payments — averaging $21.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$618
- Ironshore Pharmaceuticals Inc.$442
- AbbVie$391
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$354
- Axsome Therapeutics, Inc.$232
- Neos Therapeutics, LP$208
- plus $979 from 10 others
What the payments were for
- Food & beverage$3,17498%
- Education$492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 26 | $618 |
| Ironshore Pharmaceuticals Inc. | 21 | $442 |
| AbbVie | 16 | $391 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $354 |
| Axsome Therapeutics, Inc. | 10 | $232 |
| Neos Therapeutics, LP | 11 | $208 |
| Collegium Pharmaceutical, Inc. | 10 | $203 |
| Alkermes, Inc. | 7 | $160 |
| Otsuka America Pharmaceutical, Inc. | 9 | $145 |
| Lundbeck LLC | 6 | $122 |
| Vertical Pharmaceuticals, LLC | 5 | $80 |
| Almatica Pharma LLC | 3 | $71 |
| Supernus Pharmaceuticals, Inc. | 3 | $65 |
| Tris Pharma Inc | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| Johnson & Johnson | 1 | $24 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.